Overview

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to examine the rate at which elevated body temperature (fever) is relieved by an itraconazole injection administrated to patients experiencing neutropenic fever . A neutropenic fever is an elevated body temperature that occurs at a time when the patient's white blood cell count is low. White blood cells aid the body's normal defenses against infection, so a fever during this period might make it difficult for the patient to fight infections.
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Hydroxyitraconazole
Itraconazole